Vardenafil hydrochloride trihydrate
|
10物価
選択條件：
ブランド
- 富士フイルム和光純薬株式會社(wako)
- Sigma-Aldrich Japan
パッケージ
- y0001647
- 200mg
- y0001648
- 500MG
- 1g
- 5g
- 10g
- 25g
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQC-2658
- 製品説明
- 英語製品説明Vardenafil hydrochloride trihydrate
- 包裝単位25g
- 価格￥180000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQC-2658
- 製品説明
- 英語製品説明Vardenafil hydrochloride trihydrate
- 包裝単位10g
- 価格￥95000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQC-2658
- 製品説明
- 英語製品説明Vardenafil hydrochloride trihydrate
- 包裝単位5g
- 価格￥60000
- 更新しました2024-03-01
- 購入
- 生産者富士フイルム和光純薬株式會社(wako)
- 製品番號W01COBQC-2658
- 製品説明
- 英語製品説明Vardenafil hydrochloride trihydrate
- 包裝単位1g
- 価格￥20000
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號Y0001647
- 製品説明 European Pharmacopoeia (EP) Reference Standard
- 英語製品説明Vardenafil hydrochloride trihydrate European Pharmacopoeia (EP) Reference Standard
- 包裝単位y0001647
- 価格￥19400
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號Y0001648
- 製品説明システム適合性用バルデナフィル European Pharmacopoeia (EP) Reference Standard
- 英語製品説明Vardenafil for system suitability European Pharmacopoeia (EP) Reference Standard
- 包裝単位y0001648
- 価格￥19400
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號Y0001647
- 製品説明 European Pharmacopoeia (EP) Reference Standard
- 英語製品説明VARDENAFILHYDROCHLORIDETRIHYDRATE(SUBJECTTOPATENTFREE) European Pharmacopoeia (EP) Reference Standard
- 包裝単位
- 価格￥35200
- 更新しました2021-03-23
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號Y0001648
- 製品説明 European Pharmacopoeia (EP) Reference Standard
- 英語製品説明VARDENAFILHYDROCHLORIDETRIHYDRATE(SUBJECTTOPATENTFREE) European Pharmacopoeia (EP) Reference Standard
- 包裝単位
- 価格￥35200
- 更新しました2021-03-23
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號PHR2720
- 製品説明 certified reference material, pharmaceutical secondary standard
- 英語製品説明Vardenafil Hydrochloride certified reference material, pharmaceutical secondary standard
- 包裝単位500MG
- 価格￥40400
- 更新しました2024-03-01
- 購入
- 生産者Sigma-Aldrich Japan
- 製品番號1711010
- 製品説明 United States Pharmacopeia (USP) Reference Standard
- 英語製品説明Vardenafil hydrochloride United States Pharmacopeia (USP) Reference Standard
- 包裝単位200mg
- 価格￥54400
- 更新しました2024-03-01
- 購入
| 生産者 | 製品番號 | 製品説明 | 包裝単位 | 価格 | 更新時間 | 購入 |
|---|---|---|---|---|---|---|
| 富士フイルム和光純薬株式會社(wako) | W01COBQC-2658 | Vardenafil hydrochloride trihydrate |
25g | ￥180000 | 2024-03-01 | 購入 |
| 富士フイルム和光純薬株式會社(wako) | W01COBQC-2658 | Vardenafil hydrochloride trihydrate |
10g | ￥95000 | 2024-03-01 | 購入 |
| 富士フイルム和光純薬株式會社(wako) | W01COBQC-2658 | Vardenafil hydrochloride trihydrate |
5g | ￥60000 | 2024-03-01 | 購入 |
| 富士フイルム和光純薬株式會社(wako) | W01COBQC-2658 | Vardenafil hydrochloride trihydrate |
1g | ￥20000 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | Y0001647 | European Pharmacopoeia (EP) Reference Standard Vardenafil hydrochloride trihydrate European Pharmacopoeia (EP) Reference Standard |
y0001647 | ￥19400 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | Y0001648 | システム適合性用バルデナフィル European Pharmacopoeia (EP) Reference Standard Vardenafil for system suitability European Pharmacopoeia (EP) Reference Standard |
y0001648 | ￥19400 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | Y0001647 | European Pharmacopoeia (EP) Reference Standard VARDENAFILHYDROCHLORIDETRIHYDRATE(SUBJECTTOPATENTFREE) European Pharmacopoeia (EP) Reference Standard |
￥35200 | 2021-03-23 | 購入 | |
| Sigma-Aldrich Japan | Y0001648 | European Pharmacopoeia (EP) Reference Standard VARDENAFILHYDROCHLORIDETRIHYDRATE(SUBJECTTOPATENTFREE) European Pharmacopoeia (EP) Reference Standard |
￥35200 | 2021-03-23 | 購入 | |
| Sigma-Aldrich Japan | PHR2720 | certified reference material, pharmaceutical secondary standard Vardenafil Hydrochloride certified reference material, pharmaceutical secondary standard |
500MG | ￥40400 | 2024-03-01 | 購入 |
| Sigma-Aldrich Japan | 1711010 | United States Pharmacopeia (USP) Reference Standard Vardenafil hydrochloride United States Pharmacopeia (USP) Reference Standard |
200mg | ￥54400 | 2024-03-01 | 購入 |
プロパティ
貯蔵溫度 :under inert gas (nitrogen or Argon) at 2-8°C
溶解性 :≥13.3 mg/mL in DMSO; ≥3.42 mg/mL in EtOH with gentle warming and ultrasonic; ≥95 mg/mL in H2O
外見 :Solid
色 :White to off-white
溶解性 :≥13.3 mg/mL in DMSO; ≥3.42 mg/mL in EtOH with gentle warming and ultrasonic; ≥95 mg/mL in H2O
外見 :Solid
色 :White to off-white
安全情報
| 絵表示(GHS): |
 
|
|||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 注意喚起語: | Danger | |||||||||||||||||||||
| 危険有害性情報: |
|
|||||||||||||||||||||
| 注意書き: |
|
説明
Selective inhibitors of phosphodiesterase 5 (PDE5), which specifically hydrolyzes cGMP, are used to study signaling through the guanylate cyclase activator nitric oxide and to mediate smooth muscle relaxation and vasodilation triggered by cGMP. Vardenafil is a potent inhibitor of PDE5 (IC50 = 0.2-1.2 nM) that less effectively blocks the activities of PDE6, PDE1, and PDE11 (IC50s = 2, 230, and 130 nM, respectively). PDE5 inhibitors, including vardenafil, have applications in several conditions, including erectile dysfunction, pulmonary arterial hypertension, and lower urinary tract dysfunction.供給者とメーカー
ATK CHEMICAL COMPANY LIMITED
Hubei Jusheng Technology Co.,Ltd.
Shanghai Longyu Biotechnology Co., Ltd.
TargetMol Chemicals Inc.
Baoji Guokang Bio-Technology Co., Ltd.
InvivoChem
Nanjing Doge Biomedical Technology Co., Ltd
TargetMol Chemicals Inc.
Wuhan Topule Biopharmaceutical Co., Ltd
LEAPCHEM CO., LTD.